Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Devices
1.1.2. Technique
1.1.3. End-Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Devices outlook
2.2.2. Technique outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. TBI Assessment and Management Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.5. TBI Assessment and Management Devices Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Market Entry Strategies
Chapter 4. TBI Assessment and Management Devices Market: Devices Estimates & Trend Analysis
4.1. TBI Assessment and Management Devices Market, By Devices Key Takeaways
4.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging Devices
4.3.1. Imaging devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. Magnetic Resonance Imaging (MRI) Devices
4.3.1.1.1. Magnetic resonance imaging (MRI) devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2. X-Ray
4.3.1.2.1. X-ray market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.3. Computed Tomography
4.3.1.3.1. Computed tomography market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.4. Others
4.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Monitoring Devices
4.4.1. Monitoring devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. TBI Assessment and Management Devices Market: Technique Estimates & Trend Analysis
5.1. TBI Assessment and Management Devices Market, By Technique Key Takeaways
5.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Intracranial pressure monitoring
5.3.1. Intracranial pressure monitoring market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Partial pressure of oxygen in brain tissue (pBrO2)
5.4.1. Partial pressure of oxygen in brain tissue (pBrO2) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. TBI Assessment and Management Devices Market: End-Use Estimates & Trend Analysis
6.1. TBI Assessment and Management Devices Market, By End-Use Key Takeaways
6.2. TBI Assessment and Management Devices Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostic centers
6.4.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. TBI Assessment and Management Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. TBI Assessment and Management Devices Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. U.K.
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. Saudi Arabia
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. South Africa
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Integra Lifesciences
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. BioDirection, Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Nihon Kohden Corp.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Compumedics Ltd.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. InfraScan, Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Oculogica
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Raumedic AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/